Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Diabetes mellitus is associated with a hypercoagulable state, characterized by increased thrombin generation.
• The specific role of thrombin in the progression of diabetic nephropathy remains unclear.
• Protease-activated receptors (PARs) are key mediators of thrombin signaling.

Purpose of the Study:

• To investigate the role of thrombin receptors, specifically protease-activated receptor-1 (PAR-1) and PAR-4, in the development of diabetic nephropathy.
• To analyze the gene expression of PAR-1 and PAR-4 in the kidneys of diabetic mice.

Main Methods:

• Gene expression analysis of PAR-1 and PAR-4 mRNA in isolated glomeruli of diabetic (db/db) mice and age-matched non-diabetic littermates (db/m).
• In situ hybridization to determine the localization of PAR-1 mRNA within the kidney.
• Assessment of renal abnormalities, including mesangial expansion and urinary albumin excretion, in diabetic mice.

Main Results:

• Diabetic db/db mice exhibited hyperglycemia and renal abnormalities, including mesangial expansion and albuminuria, by 10 weeks of age.
• PAR-1 mRNA levels were significantly upregulated in the glomeruli of diabetic mice compared to controls.
• PAR-4 mRNA expression did not differ between diabetic and control mice.
• In situ hybridization revealed prominent PAR-1 mRNA expression in glomerular mesangial cells and podocytes.

Conclusions:

• The upregulation of PAR-1 in the glomeruli of diabetic mice suggests a potential role for this receptor in the pathogenesis of diabetic nephropathy.
• PAR-1 may contribute to glomerulosclerosis and abnormal urinary albumin excretion observed in diabetic kidney disease.
• Targeting PAR-1 could be a potential therapeutic strategy for managing diabetic nephropathy.